Joseph Shulman
Technik-/Wissenschafts-/F&E-Leiter bei RHYTHM PHARMACEUTICALS, INC.
Vermögen: 1 070 $ am 31.05.2024
Profil
Joseph Shulman is currently the Chief Technical Officer at Rhythm Pharmaceuticals, Inc. He previously held the position of Senior Vice President-Technical Operations at Ra Pharmaceuticals, Inc. from 2019 to 2020, and Senior Vice President-Global Technical Operations at Novelion Therapeutics, Inc. from 2014 to 2019.
Mr. Shulman holds an MBA from Boston University and an undergraduate degree from the University of Miami.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 09.05.2024 | 30 ( 0,00% ) | 1 070 $ | 31.05.2024 |
Aktive Positionen von Joseph Shulman
| Unternehmen | Position | Beginn |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 27.07.2020 |
Ehemalige bekannte Positionen von Joseph Shulman
| Unternehmen | Position | Ende |
|---|---|---|
| RA PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2020 |
| NOVELION THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2019 |
Ausbildung von Joseph Shulman
| Boston University | Masters Business Admin |
| University of Miami | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelion Therapeutics, Inc. engaged in the development and commercialization of pharmaceuitical products. It focused in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and was headquartered in Vancouver, Canada. | Health Technology |
